Agennix (GPC Biotech) agennix.com

Agennix, formed by the combination of GPC Biotech AG and Agennix Incorporated in 2009, is a biopharmaceutical company focused on developing anti-cancer therapies. The Company's most advanced program is talactoferrin, an oral targeted therapy that is in Phase 3 clinical trials in non-small cell lung cancer.

Agennix, formed by the combination of GPC Biotech AG and Agennix Incorporated in 2009, is a biopharmaceutical company focused on developing anti-cancer therapies. The Company's most advanced program is talactoferrin, an oral targeted therapy that is ...Show all

See All Exits Recent Exits

Phone:

Fax:

101 College Road East

08540
New Jersey, United States

Agennix (GPC Biotech) - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2009-02-12AgennixAcquired
2000-03-06GPC BiotechAcquired
See all 2 investments